Skip to main content

Table 3 Baseline Demographics and Clinical Characteristics, by Bleeding-related Complication and/or Blood Product Transfusion Status

From: Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients

Characteristic Complication* No Complication P-value
Number of patients 351,065 1,175,208  
Age, mean years (SD) 64.0 (17.9) 55.1 (18.7) < 0.001
   Range 1-89 1-89  
Male, N (%) 159,893 (45.5%) 432,211 (36.8%) < 0.001
Race, N (%)    
   White 231,146 (65.8%) 770,920 (65.6%) < 0.001
   Black 46,288 (13.2%) 143,269 (12.2%)  
   Hispanic 12,842 (3.7%) 58,358 (5.0%)  
   Other 60,789 (17.3%) 202,661 (17.2%)  
Geographic Region, N (%)    
   Northeast 57,899 (16.5%) 163,160 (13.9%) < 0.001
   South 170,133 (48.5%) 537,047 (45.7%)  
   Midwest 60,598 (17.3%) 259,391 (22.1%)  
   West 58,970 (16.8%) 204,439 (17.4%)  
   Unknown 3,465 (1.0%) 11,171 (1.0%)  
Primary Payer, N (%)    
   Medicare 202,495 (57.7%) 443,685 (37.8%) < 0.001
   Medicaid 24,477 (7.0%) 110,654 (9.4%)  
   Private 98,132 (28.0%) 524,710 (44.6%)  
   Uninsured 13,495 (3.8%) 45,219 (3.8%)  
   Other 12,466 (3.6%) 50,940 (4.3%)  
Comorbidity, N (%)    
   Diabetes 162,097 (46.2%) 306,512 (26.1%) < 0.001
   Obesity 41,646 (11.9%) 150,510 (12.8%) < 0.001
   COPD 88,506 (25.2%) 219,635 (18.7%) < 0.001
   Cancer 80,506 (22.9%) 198,206 (16.9%) < 0.001
   Cirrhosis 11,034 (3.1%) 9,835 (0.8%) < 0.001
Prior Hospitalization, N (%) 161,956 (46.1%) 486,348 (41.4%) < 0.001
Prior Surgery, N (%) 106,064 (30.2%) 293,533 (25.0%) < 0.001
Pre-operative use of substances that promote hemostasis, N (%) 7,957 (2.3%) 21,338 (1.8%) < 0.001
  1. N = number of patients, SD = standard deviation
  2. *Bleeding complication and/or blood product transfusion